questionsmedicales.fr
Maladies cardiovasculaires
Maladies vasculaires
Ischémie myocardique
Maladie coronarienne
Sténose coronarienne
Resténose coronaire
Resténose coronaire : Questions médicales fréquentes
Termes MeSH sélectionnés :
Diagnostic
5
Resténose coronaire
Angiographie
Tests d'effort
Échographie intravasculaire
Angiographie
Resténose coronaire
Douleur thoracique
Essoufflement
Resténose coronaire
Scintigraphie cardiaque
Perfusion myocardique
Resténose coronaire
Angioplastie
Ischémie
Resténose coronaire
Symptômes
5
Douleur thoracique
Fatigue
Essoufflement
Asymptomatique
Resténose coronaire
Symptômes
Douleur thoracique
Sensation de serrement
Resténose coronaire
Symptômes
Variabilité
Resténose coronaire
Consultation médicale
Douleur thoracique
Resténose coronaire
Prévention
5
Prévention
Mode de vie sain
Facteurs de risque
Cholestérol
Prévention
Resténose coronaire
Exercice
Santé cardiaque
Prévention
Contrôles médicaux
Santé cardiaque
Prévention
Stress
Santé cardiaque
Resténose coronaire
Traitements
5
Revascularisation
Médicaments
Resténose coronaire
Stents
Stents médicamenteux
Resténose coronaire
Médicaments antiagrégants
Caillots
Resténose coronaire
Chirurgie de pontage
Resténose coronaire
Traitements
Surveillance
Tests d'effort
Resténose coronaire
Complications
5
Angine de poitrine
Infarctus du myocarde
Complications
Infarctus du myocarde
Resténose coronaire
Risque
Qualité de vie
Activité physique
Resténose coronaire
Complications
Gestion
Resténose coronaire
Douleurs thoraciques
Complications
Urgence médicale
Facteurs de risque
5
Tabagisme
Hypertension
Diabète
Âge
Risque
Resténose coronaire
Diabète
Risque
Resténose coronaire
Mode de vie sédentaire
Risque
Resténose coronaire
Stress
Hypertension
Risque
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Resténose coronaire : Questions médicales les plus fréquentes",
"headline": "Resténose coronaire : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Resténose coronaire : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-01-19",
"dateModified": "2025-04-13",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Resténose coronaire"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Sténose coronarienne",
"url": "https://questionsmedicales.fr/mesh/D023921",
"about": {
"@type": "MedicalCondition",
"name": "Sténose coronarienne",
"code": {
"@type": "MedicalCode",
"code": "D023921",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C14.907.585.250.285"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Resténose coronaire",
"alternateName": "Coronary Restenosis",
"code": {
"@type": "MedicalCode",
"code": "D023903",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Tommaso Gori",
"url": "https://questionsmedicales.fr/author/Tommaso%20Gori",
"affiliation": {
"@type": "Organization",
"name": ""
}
},
{
"@type": "Person",
"name": "Moa Pehrson",
"url": "https://questionsmedicales.fr/author/Moa%20Pehrson",
"affiliation": {
"@type": "Organization",
"name": "Perinatal and Cardiovascular Epidemiology Lund University Diabetes Centre, Clinical Sciences Malmö, Lund University Malmö Sweden."
}
},
{
"@type": "Person",
"name": "Giovanna Sarno",
"url": "https://questionsmedicales.fr/author/Giovanna%20Sarno",
"affiliation": {
"@type": "Organization",
"name": "Department of Medical Sciences Cardiology and Uppsala Clinical Research Center, Uppsala University Uppsala Sweden."
}
},
{
"@type": "Person",
"name": "Abigail Fraser",
"url": "https://questionsmedicales.fr/author/Abigail%20Fraser",
"affiliation": {
"@type": "Organization",
"name": "Population Health Science, Bristol Medical School University of Bristol Bristol United Kingdom."
}
},
{
"@type": "Person",
"name": "Janet W Rich-Edwards",
"url": "https://questionsmedicales.fr/author/Janet%20W%20Rich-Edwards",
"affiliation": {
"@type": "Organization",
"name": "Division of Women's Health Department of Medicine, Brigham and Women's Hospital and Harvard Medical School Boston MA."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Communication Overload in Hospitals: Exploring Organizational Safety Communication, Worker Job Attitudes, and Communication Efficacy.",
"datePublished": "2022-09-29",
"url": "https://questionsmedicales.fr/article/36172847",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1080/10410236.2022.2129313"
}
},
{
"@type": "ScholarlyArticle",
"name": "Strategic communication as planned behavior for science and risk communication: A theory-based approach to studying communicator choice.",
"datePublished": "2022-09-18",
"url": "https://questionsmedicales.fr/article/36116781",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1111/risa.14029"
}
},
{
"@type": "ScholarlyArticle",
"name": "Communication Openings: A Novel Approach for Serious Illness Communication in Homecare.",
"datePublished": "2023-11-01",
"url": "https://questionsmedicales.fr/article/37906048",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3928/00989134-20231011-02"
}
},
{
"@type": "ScholarlyArticle",
"name": "Everyday Barriers in Communicative Participation According to People With Communication Problems.",
"datePublished": "2023-02-14",
"url": "https://questionsmedicales.fr/article/36787154",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1044/2022_JSLHR-22-00405"
}
},
{
"@type": "ScholarlyArticle",
"name": "Beyond dyadic communication: Network of communication in inflammatory arthritis teams.",
"datePublished": "2022-05-29",
"url": "https://questionsmedicales.fr/article/35635126",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1177/17423953221102629"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Maladies cardiovasculaires",
"item": "https://questionsmedicales.fr/mesh/D002318"
},
{
"@type": "ListItem",
"position": 3,
"name": "Maladies vasculaires",
"item": "https://questionsmedicales.fr/mesh/D014652"
},
{
"@type": "ListItem",
"position": 4,
"name": "Ischémie myocardique",
"item": "https://questionsmedicales.fr/mesh/D017202"
},
{
"@type": "ListItem",
"position": 5,
"name": "Maladie coronarienne",
"item": "https://questionsmedicales.fr/mesh/D003327"
},
{
"@type": "ListItem",
"position": 6,
"name": "Sténose coronarienne",
"item": "https://questionsmedicales.fr/mesh/D023921"
},
{
"@type": "ListItem",
"position": 7,
"name": "Resténose coronaire",
"item": "https://questionsmedicales.fr/mesh/D023903"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Resténose coronaire - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Resténose coronaire",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-03",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Resténose coronaire",
"description": "Comment diagnostique-t-on la resténose coronaire ?\nQuels examens sont utilisés pour évaluer la resténose ?\nQuels symptômes peuvent indiquer une resténose ?\nLa scintigraphie cardiaque est-elle utile ?\nQuand faut-il suspecter une resténose après une angioplastie ?",
"url": "https://questionsmedicales.fr/mesh/D023903?mesh_terms=Communication#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Resténose coronaire",
"description": "Quels sont les symptômes courants de la resténose ?\nLa resténose peut-elle être asymptomatique ?\nComment la douleur thoracique se manifeste-t-elle ?\nLes symptômes varient-ils selon les patients ?\nQuand consulter un médecin pour des symptômes ?",
"url": "https://questionsmedicales.fr/mesh/D023903?mesh_terms=Communication#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Resténose coronaire",
"description": "Comment prévenir la resténose coronaire ?\nLe contrôle du cholestérol aide-t-il à prévenir la resténose ?\nL'exercice régulier est-il bénéfique ?\nLes contrôles médicaux réguliers sont-ils importants ?\nLe stress peut-il influencer la resténose ?",
"url": "https://questionsmedicales.fr/mesh/D023903?mesh_terms=Communication#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Resténose coronaire",
"description": "Quels traitements sont disponibles pour la resténose ?\nLes stents sont-ils efficaces contre la resténose ?\nQuel rôle jouent les médicaments antiagrégants ?\nLa chirurgie est-elle une option pour la resténose ?\nComment la surveillance post-interventionnelle est-elle effectuée ?",
"url": "https://questionsmedicales.fr/mesh/D023903?mesh_terms=Communication#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Resténose coronaire",
"description": "Quelles complications peuvent survenir avec la resténose ?\nLa resténose augmente-t-elle le risque d'infarctus ?\nComment la resténose affecte-t-elle la qualité de vie ?\nLes complications sont-elles réversibles ?\nQuels signes indiquent une complication grave ?",
"url": "https://questionsmedicales.fr/mesh/D023903?mesh_terms=Communication#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Resténose coronaire",
"description": "Quels sont les principaux facteurs de risque de resténose ?\nL'âge influence-t-il le risque de resténose ?\nLe diabète est-il un facteur de risque ?\nLe mode de vie sédentaire est-il un facteur de risque ?\nLe stress peut-il aggraver les facteurs de risque ?",
"url": "https://questionsmedicales.fr/mesh/D023903?mesh_terms=Communication#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostique-t-on la resténose coronaire ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle est diagnostiquée par angiographie coronarienne et tests d'effort."
}
},
{
"@type": "Question",
"name": "Quels examens sont utilisés pour évaluer la resténose ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'angiographie et l'échographie intravasculaire sont couramment utilisés."
}
},
{
"@type": "Question",
"name": "Quels symptômes peuvent indiquer une resténose ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des douleurs thoraciques ou un essoufflement peuvent signaler une resténose."
}
},
{
"@type": "Question",
"name": "La scintigraphie cardiaque est-elle utile ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle peut aider à détecter des zones de mauvaise perfusion myocardique."
}
},
{
"@type": "Question",
"name": "Quand faut-il suspecter une resténose après une angioplastie ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Si le patient présente des symptômes d'ischémie dans les mois suivant l'intervention."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes courants de la resténose ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent douleur thoracique, fatigue et essoufflement à l'effort."
}
},
{
"@type": "Question",
"name": "La resténose peut-elle être asymptomatique ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains patients ne présentent aucun symptôme malgré la resténose."
}
},
{
"@type": "Question",
"name": "Comment la douleur thoracique se manifeste-t-elle ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle peut être ressentie comme une pression ou une sensation de serrement dans la poitrine."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils selon les patients ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'intensité et la nature des symptômes peuvent varier d'un patient à l'autre."
}
},
{
"@type": "Question",
"name": "Quand consulter un médecin pour des symptômes ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il est conseillé de consulter immédiatement en cas de douleur thoracique persistante."
}
},
{
"@type": "Question",
"name": "Comment prévenir la resténose coronaire ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un mode de vie sain, l'arrêt du tabac et la gestion des facteurs de risque sont essentiels."
}
},
{
"@type": "Question",
"name": "Le contrôle du cholestérol aide-t-il à prévenir la resténose ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, maintenir un taux de cholestérol sain réduit le risque de resténose."
}
},
{
"@type": "Question",
"name": "L'exercice régulier est-il bénéfique ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'exercice régulier améliore la santé cardiaque et peut prévenir la resténose."
}
},
{
"@type": "Question",
"name": "Les contrôles médicaux réguliers sont-ils importants ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils permettent de surveiller la santé cardiaque et d'ajuster les traitements."
}
},
{
"@type": "Question",
"name": "Le stress peut-il influencer la resténose ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le stress chronique peut aggraver les problèmes cardiaques et favoriser la resténose."
}
},
{
"@type": "Question",
"name": "Quels traitements sont disponibles pour la resténose ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements incluent la revascularisation, les médicaments et la surveillance."
}
},
{
"@type": "Question",
"name": "Les stents sont-ils efficaces contre la resténose ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les stents, surtout les stents médicamenteux, réduisent le risque de resténose."
}
},
{
"@type": "Question",
"name": "Quel rôle jouent les médicaments antiagrégants ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils aident à prévenir la formation de caillots et à réduire le risque de resténose."
}
},
{
"@type": "Question",
"name": "La chirurgie est-elle une option pour la resténose ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, dans certains cas, une chirurgie de pontage peut être nécessaire."
}
},
{
"@type": "Question",
"name": "Comment la surveillance post-interventionnelle est-elle effectuée ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle implique des contrôles réguliers et des tests d'effort pour évaluer la fonction cardiaque."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec la resténose ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent l'angine de poitrine, l'infarctus du myocarde et l'insuffisance cardiaque."
}
},
{
"@type": "Question",
"name": "La resténose augmente-t-elle le risque d'infarctus ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la resténose peut augmenter le risque d'infarctus du myocarde."
}
},
{
"@type": "Question",
"name": "Comment la resténose affecte-t-elle la qualité de vie ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle peut limiter l'activité physique et entraîner des douleurs chroniques."
}
},
{
"@type": "Question",
"name": "Les complications sont-elles réversibles ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines complications peuvent être gérées, mais d'autres peuvent être permanentes."
}
},
{
"@type": "Question",
"name": "Quels signes indiquent une complication grave ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des douleurs thoraciques sévères, des sueurs ou des nausées doivent alerter immédiatement."
}
},
{
"@type": "Question",
"name": "Quels sont les principaux facteurs de risque de resténose ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent le tabagisme, l'hypertension, le diabète et l'hyperlipidémie."
}
},
{
"@type": "Question",
"name": "L'âge influence-t-il le risque de resténose ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le risque de resténose augmente avec l'âge."
}
},
{
"@type": "Question",
"name": "Le diabète est-il un facteur de risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le diabète augmente significativement le risque de resténose."
}
},
{
"@type": "Question",
"name": "Le mode de vie sédentaire est-il un facteur de risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un mode de vie sédentaire contribue à l'augmentation du risque de resténose."
}
},
{
"@type": "Question",
"name": "Le stress peut-il aggraver les facteurs de risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le stress peut exacerber d'autres facteurs de risque comme l'hypertension."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 13/04/2025
Contenu vérifié selon les dernières recommandations médicales
2 publications dans cette catégorie
Publications dans "Resténose coronaire" :
2 publications dans cette catégorie
Affiliations :
Perinatal and Cardiovascular Epidemiology Lund University Diabetes Centre, Clinical Sciences Malmö, Lund University Malmö Sweden.
Publications dans "Resténose coronaire" :
2 publications dans cette catégorie
Affiliations :
Department of Medical Sciences Cardiology and Uppsala Clinical Research Center, Uppsala University Uppsala Sweden.
Publications dans "Resténose coronaire" :
2 publications dans cette catégorie
Affiliations :
Population Health Science, Bristol Medical School University of Bristol Bristol United Kingdom.
Publications dans "Resténose coronaire" :
2 publications dans cette catégorie
Affiliations :
Division of Women's Health Department of Medicine, Brigham and Women's Hospital and Harvard Medical School Boston MA.
Publications dans "Resténose coronaire" :
2 publications dans cette catégorie
Affiliations :
Perinatal and Cardiovascular Epidemiology Lund University Diabetes Centre, Clinical Sciences Malmö, Lund University Malmö Sweden.
Publications dans "Resténose coronaire" :
2 publications dans cette catégorie
Affiliations :
Perinatal and Cardiovascular Epidemiology Lund University Diabetes Centre, Clinical Sciences Malmö, Lund University Malmö Sweden.
Department of Obstetrics and Gynecology Skåne University Hospital Malmö Sweden.
Publications dans "Resténose coronaire" :
2 publications dans cette catégorie
Affiliations :
The Zena and Michael A. Wiener Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Publications dans "Resténose coronaire" :
2 publications dans cette catégorie
Affiliations :
The Zena and Michael A. Wiener Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Publications dans "Resténose coronaire" :
2 publications dans cette catégorie
Affiliations :
The Zena and Michael A. Wiener Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, New York, New York, USA. Electronic address: samin.sharma@mountsinai.org.
Publications dans "Resténose coronaire" :
2 publications dans cette catégorie
Affiliations :
Department of Medical Biotechnology and Nanotechnology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad 9177948564, Iran.
Publications dans "Resténose coronaire" :
2 publications dans cette catégorie
Affiliations :
Bioinformatics Research Group, Mashhad University of Medical Sciences, Mashhad 9177948564, Iran.
Publications dans "Resténose coronaire" :
2 publications dans cette catégorie
Affiliations :
Applied Biomedical Research Center, Mashhad University of Medical Sciences, Mashhad 9177948564, Iran.
Biotechnology Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad 9177948954, Iran.
School of Medicine, The University of Western Australia, Perth, WA 6009, Australia.
Department of Biotechnology, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad 9177948954, Iran.
Publications dans "Resténose coronaire" :
2 publications dans cette catégorie
Affiliations :
Department of Endocrinology, Instituto Nacional de Cardiología Ignacio Chávez, Mexico City, Mexico.
Publications dans "Resténose coronaire" :
2 publications dans cette catégorie
Affiliations :
Department of Molecular Biology, Instituto Nacional de Cardiología Ignacio Chávez, Juan Badiano 1, Sección XVI, Del. Tlalpan, 14080, Mexico City, Mexico. gvargas63@yahoo.com.
Publications dans "Resténose coronaire" :
2 publications dans cette catégorie
Affiliations :
Section of Interventional Cardiology, MedStar Washington Hospital Center, Washington, District of Columbia.
Publications dans "Resténose coronaire" :
2 publications dans cette catégorie
Affiliations :
Section of Interventional Cardiology, MedStar Washington Hospital Center, Washington, District of Columbia. Electronic address: ron.waksman@medstar.net.
Publications dans "Resténose coronaire" :
2 publications dans cette catégorie
Affiliations :
Division of Cardiology, Department of Medicine, Columbia University Medical Center, New York, NY, USA.
Clinical Trials Center, Cardiovascular Research Foundation, New York, NY, USA.
Publications dans "Resténose coronaire" :
2 publications dans cette catégorie
Affiliations :
Unit of Interventional Cardiology, Mediterranea Cardiocentro, Naples, Italy.
Department of Medical-Surgical Sciences and Biotechnologies, Sapienza University, Latina, Italy.
Publications dans "Resténose coronaire" :
2 publications dans cette catégorie
Affiliations :
Carle Heart & Vascular Institute, Carle Illinois College of Medicine, University of Illinois UC, Champaign, Illinois. Electronic address: imoussa@illinois.edu.
Publications dans "Resténose coronaire" :
Hospitals represent complex organizations where a range of hospital workers, from physicians to administrators, encounter a deluge of information they must quickly process and act upon. New technologi...
This essay argues that we should treat science and risk communicators' choices about tactics, objectives, and goals as behaviors to advance both research and practice. Doing so allows for a discussion...
Serious illness communication in homecare about hospice and/or palliative care transitions is lacking due to clinical culture. The purpose of the current study was to understand communication openings...
The purpose of this study was to gain a comprehensive understanding of participation situations that are challenging for people with communication problems, to provide input for the further developmen...
A purposive sampling strategy was used to include a diverse group of people with communication problems. Diaries were used as a sensitizing exercise for inductive in-depth interviews. In these intervi...
Eighteen interviews yielded 44 different concepts. They were clustered in six themes, which capture the person, location, topic, mode, moment, and pace of communication. In total, 103 new items measur...
This study resulted in an overview of self-reported barriers in daily communicative participation experienced by people with communication problems. These communicative participation situations can be...
To explore how communication is perceived and care is negotiated amongst IA healthcare teams by drawing on the perspectives of each team member....
This analysis drew on data from an ongoing three-year study exploring team-based IA care. We interviewed 11 participants including two men with IA and their family care providers and healthcare provid...
Analysis revealed three themes regarding communication and care: (1) seeking/sharing information, (2) striving to coordinate unified care, and (3) providing patients a voice....
This study emphasizes the importance of understanding team dynamics beyond the dyad of patient and care provider. Negotiating power and decision-making in IA care is a dynamic process involving shifti...
To analyze the effect of communication training developed for adolescents on the youth's communication skills....
Forty-one young people participated in the study and were divided into two groups. Group I received intervention - communication training for five weeks; Group II - were guided on the importance of vo...
The analysis of questionnaires showed improvement in GI in two of the four skills assessed and no difference for GII. The video evaluations showed a significant difference between the groups in terms ...
This study points out that the communication training method applied to young people might improve communicative skills, providing some insights into their communication strengths and potential areas ...
Humans often communicate using body movements like winks, waves, and nods. However, it is unclear how we identify when someone's physical actions are communicative. Given people's propensity to interp...
The consequences of ineffective communication between patients and clinicians in the ED range from frustration to significant adverse events. Unfortunately, scenarios where we are unable to understand...
Many people with amyotrophic lateral sclerosis (PALS) experience speech changes, which may interfere with participation in communication situations. This study was designed to investigate the effects ...
Participants with amyotrophic lateral sclerosis completed an online questionnaire in which they identified their current communication methods, rated their speech function, and rated their communicati...
Communication aids appeared to support communicative participation for many participants with dysarthria. Across all levels of speech function, PALS who use aided communication reported better partici...
Aided communication can help PALS continue to participate in various communication situations as their speech function deteriorates. Variability in self-rated communicative participation, even for PAL...
https://doi.org/10.23641/asha.22782986....
Research has found that people with communication disabilities are three times more likely to encounter medical mishaps. Almost a third of patients with speech-language therapy (SLT) diagnoses have ot...
This study aims to describe the communication challenges and strategies employed by a group of final year Nursing, Medicine, Dietetics and Human Nutrition, Physiotherapy and Occupational Therapy stude...
A qualitative, phenomenological study design was used. Questionnaires were electronically distributed, and results were analysed thematically....
The most significant challenges whilst managing adults with communication disorders were patients' receptive and expressive language difficulties. Further challenges included lack of knowledge surroun...
This study revealed that there is a need to develop healthcare students' skills in managing adults with communication disorders. This is because of the challenges faced and inefficiency of the strateg...